ABIM Credit Rules Are Now Clinicians’ CME Constraint

Clinician frustration with ABIM and MOC this week centered less on learning itself than on credit mechanics, stale assessment content, and whether real clinical work counts. The current sample is oncology/hematology-led, so CME teams should test the same friction points in other specialties rather than treating this as universal proof.

MOC burden is a format problem, not just a compliance problem

In one detailed thread, an oncologist described being overseas when his hospital credentialing department was told he was no longer MOC-compliant after 4.75 previously earned credits lapsed, sending him into a late-night scramble across approved education sites (source). The same thread was not anti-learning; he noted useful resources and pointed to tumor board leadership as meaningful competence work that his employer considers CME-worthy but ABIM does not. The provider lesson is simple: if credit expires, fails to transfer cleanly, or forces clinicians into duplicative scavenger hunts, the educational value can be overwhelmed by administrative mistrust.

That mistrust was reinforced by assessment-content complaints. A hematologist said an MDS LKA question was wrong for the second quarter because, “In both instances, questions were not updated to reflect recent updates, which speaks to how outdated this approach is” (source). Another clinician in the same thread described an ABIM MOC bladder-cancer item as lagging behind the clinical evidence he used in practice. A separate hematology thread criticized the premise that routine testing on non-germane topics reliably translates to better care (source). These are not requests for easier education. They are objections to learning systems that appear disconnected from the pace and setting of practice.

The continuity matters. In an April brief on ABIM bureaucracy, the signal was that oncologists were treating certification as a bureaucratic tax. This week’s examples make the design ask sharper: CME providers need to reduce the moments where the clinician has to prove learning twice—once in practice and again in a portal. Even a short post framing trust around MOC currency (source) shows the bind: certification status remains institutionally consequential, even when clinicians question whether the process measures current competence.

The implication is not to campaign against MOC. It is to design as if MOC friction is part of the learner’s environment. For MOC-adjacent activities, CME teams should ask: will this credit be easy to claim, easy to verify, easy to carry across systems, and clearly tied to current evidence or real clinical work?

What CME Providers Should Do Now

• Audit MOC-linked activities for four failure points: expiration visibility, claim steps, transcript portability, and verifier handoff.
• Add clear “current as of” dates and update-review triggers to assessments in fast-changing clinical areas.
• Where eligible, design tumor board or case-conference pathways that convert real-world competence work into documented credit without duplicative testing.
• Test learner-facing copy that frames MOC support as reducing administrative burden, not as gamifying certification.

What CME teams should reconsider

The week’s useful change is specificity. Clinicians were not only venting about ABIM; they were describing exactly where the learning system breaks: earned credits disappearing, assessment items lagging evidence, and high-value clinical learning not counting where it matters.

A MOC-linked activity that ignores those breakpoints may still be accredited, but it will feel like another layer of work. The stronger planning question is which activities can make competence easier to document without making clinicians relive the bureaucracy they came to CME to escape.